Open access · OA
via OpenAlex
Metformin as a Geroprotective Agent: Multifaceted Mechanisms Targeting Cellular Senescence and Aging Hallmarks
Biocell · 2026
Epigenetic alterations
Deregulated nutrient-sensing
Mitochondrial dysfunction
Cellular senescence
Senolytics
Metformin
Human
Mouse
Preclinical / animal
Review
Abstract
Metformin is widely recognized for its pleiotropic effects on aging hallmarks, yet the evidence remains descriptive and mechanistically fragmented. This is a mechanism-focused narrative review; the evidence is illustrative rather than being systematically retrieved. We critically evaluate the proposed geroprotective mechanisms of metformin, including AMP-activated protein kinase activation (AMPK), mitochondrial complex I inhibition, senescence(definition)-associated secretory phenotype (SASP) suppression, and epigenetic modulation. While ample data support these pathways in preclinical models, resolving the relative contribution of these pathways requires: (i) locus-specific analysis of context-dependent H3K27me3 regulation (reported as both increased and decreased), and (ii) direct testing of AMPK-dependent versus AMPK-independent pathways in aged organisms using tissue-specific AMPK-knockout mice and chromatin profiling at SASP gene promoters. We provide specific, falsifiable predictions and experimental designs for each of these requirements in the main text. Existing studies have overgeneralized the senolytic capacity of metformin because they lack a comprehensive assessment of context-dependent effects. Further validation through rigorous human clinical trials (e.g., the ongoing Targeting Aging with Metformin study) is required, along with a clear dissection of AMPK-dependent versus AMPK-independent mechanisms, which is necessary to guide rational repurposing of metformin for aging intervention.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.32604/biocell.2026.083060
- Canonical
- link ↗
- Fetched
- 2026-10-05 MST
Cite this
APA
Zhao, Y., & Gao, L. (2026). Metformin as a Geroprotective Agent: Multifaceted Mechanisms Targeting Cellular Senescence and Aging Hallmarks. <em>Biocell</em>. https://doi.org/10.32604/biocell.2026.083060
Vancouver
Zhao Y, Gao L. Metformin as a Geroprotective Agent: Multifaceted Mechanisms Targeting Cellular Senescence and Aging Hallmarks. Biocell. 2026. doi:10.32604/biocell.2026.083060.
BibTeX
@article{yiting2026Metfor,
title = {Metformin as a Geroprotective Agent: Multifaceted Mechanisms Targeting Cellular Senescence and Aging Hallmarks},
author = {Yiting Zhao and Lei Gao},
journal = {Biocell},
year = {2026},
doi = {10.32604/biocell.2026.083060},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Ageing Research Reviews 2025
Open access · CC-BY
Liver X receptors and the hallmarks of aging: From molecular mechanisms to therapeutic opportunities
INTERNATIONAL BLEST SCIENTIFIC 2026
Open access · OA
OZONE THERAPY: ITS METABOLIC AND TRANSLATIONAL ROLE IN THE HALLMARKS OF AGING
Aging and Disease 2021
Open access · CC-BY
Metformin: A Potential Candidate for Targeting Aging Mechanisms
Nutrients 2026
Open access · CC-BY
Dietary Polyphenols in Brain Aging: Molecular Mechanisms and Implications for Neurodegeneration
Frontiers in immunology 2026
Citation only
Immune-metabolic convergence in skeletal remodeling disorders: shared osteoimmune, senescent and lipid mechanisms across aging-related and immune-mediated bone disease.
Journal of Education Health and Sport 2026
Open access · CC-BY